Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke

US Patent 6946438 · Granted Sep 20, 2005

Assignee

Inventors

View full patent text on Google Patents →